Business Description
Redx Pharma PLC
ISIN : GB00BSNB6S51
Description
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in the UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration, and Research and preclinical development services.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.02 | |||||
Equity-to-Asset | 0.13 | |||||
Debt-to-Equity | 5.27 | |||||
Debt-to-EBITDA | -0.59 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -8.36 | |||||
Beneish M-Score | 0.22 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -26.7 | |||||
3-Year EBITDA Growth Rate | -26.9 | |||||
3-Year EPS without NRI Growth Rate | -21.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.34 | |||||
9-Day RSI | 64.65 | |||||
14-Day RSI | 57.69 | |||||
6-1 Month Momentum % | -28.85 | |||||
12-1 Month Momentum % | -43.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.86 | |||||
Days Sales Outstanding | 2.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.7 | |||||
Shareholder Yield % | -0.28 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -737.27 | |||||
Net Margin % | -789.05 | |||||
FCF Margin % | -831.56 | |||||
ROE % | -192.76 | |||||
ROA % | -75.95 | |||||
ROIC % | -123.66 | |||||
ROC (Joel Greenblatt) % | -1326.31 | |||||
ROCE % | -164.69 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.54 | |||||
PB Ratio | 15 | |||||
Price-to-Tangible-Book | 15 | |||||
EV-to-EBIT | -1.87 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-Forward-EBITDA | -2.72 | |||||
EV-to-Revenue | 13.79 | |||||
EV-to-Forward-Revenue | 3.87 | |||||
EV-to-FCF | -1.66 | |||||
Earnings Yield (Greenblatt) % | -53.48 | |||||
FCF Yield % | -59.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redx Pharma PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 4.202 | ||
EPS (TTM) (£) | -0.099 | ||
Beta | 0 | ||
Volatility % | 34.26 | ||
14-Day RSI | 57.69 | ||
14-Day ATR (£) | 0.036378 | ||
20-Day SMA (£) | 0.09445 | ||
12-1 Month Momentum % | -43.08 | ||
52-Week Range (£) | 0.04 - 0.379 | ||
Shares Outstanding (Mil) | 388.99 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redx Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redx Pharma PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Redx Pharma PLC Frequently Asked Questions
What is Redx Pharma PLC(LSE:REDX)'s stock price today?
The current price of LSE:REDX is £0.15. The 52 week high of LSE:REDX is £0.38 and 52 week low is £0.04.
When is next earnings date of Redx Pharma PLC(LSE:REDX)?
The next earnings date of Redx Pharma PLC(LSE:REDX) is 2024-12-13 Est..
Does Redx Pharma PLC(LSE:REDX) pay dividends? If so, how much?
Redx Pharma PLC(LSE:REDX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |